The Impact of SNAP-Ed Among Bhutanese Adults Residing in New Hampshire

Not Applicable

Completed

• Conditions: Supplemental Nutrition Assistance Program Education; Bhutanese Refugee Adults
• Interventions: Behavioral: Direct SNAP-Ed

• Registration Number: NCT06445452
• Lead Sponsor: University of New Hampshire

Brief Summary

The goal of this pilot randomized controlled trial is to test the potential efficacy of Supplemental Nutrition Assistance Program Education (SNAP-Ed) among Bhutanese refugee adults residing in New Hampshire. The main questions are whether direct SNAP-Ed delivered through 6 lessons affects dietary quality and biomarkers of metabolic risk. Participants in the SNAP-Ed arm will be asked to participate in weekly lessons delivered in their homes by a bicultural and bilingual nutrition educator. Individuals in the control group did not receive SNAP-ED. All participants will be asked to complete surveys and provide blood and fecal samples prior at baseline and at the end of the study period (7 to 8 weeks).

Detailed Description

Not available

Study Timeline

• Study Start: 2019-10-01
• Primary Completion: 2020-02-20
• Study Completion: 2023-09-30
• Status Verified: 2024-05
• Study First Submitted: 2024-05-31
• Study First Submitted QC: 2024-05-31
• Last Update Submitted: 2024-05-31
• Study First Posted: 2024-06-06
• Last Update Posted: 2024-06-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
SNAP-Ed	Direct SNAP-Ed	-
No SNAP-Ed	Direct SNAP-Ed	-

Primary Outcome Measures

Name	Time	Method
Glucose Homeostasis Biomarkers	0 and 7-8 weeks	Homeostasis Model Assessment for Insulin Resistance (HOMA-IR) is calculated using fasting insulin and glucose values, where a higher values indicates greater insulin resistance. HbA1c will also be measured.
Lipid Panel	0 and 7-8 weeks	Total cholesterol, LDL-Cholesterol, HDL-Cholesterol and triglycerides will be measured as an indicators of CVD risk.
Gut Microbiome Composition	0 and 7-8 weeks	Outcomes include short-chain fatty acids (Akkermansia municiphilla, Ruminococcus bromii, Faecalibacterium prausnitzii, Eubacterium rectale, and Eubacterium hallii) and lower abundance of those that synthesize branched-chain amino acids (Bacillus-Lactobacillus-Streptococcus groups, and Proteobacteria). In addition, gut microbial diversity will be assessed.
Healthy Eating Index Score	0 and 7-8 weeks	All participants will provide three 24-hr recalls at baseline and the exit visit. Dietary intake will be average across the three recalls. The HEI score rubric will be applied to the dietary intakes where a higher score indicates greater adherence to the US Dietary Guidelines.
Inflammatory Biomarkers	0 and 7-8 weeks	TNF-alpha, C-Reactive Protein, and IL-6 will be measured where higher values indicate greater inflammation.

Trial Locations

Locations (1)

Building Community in New Hampshire; 🇺🇸 Manchester, New Hampshire, United States